T ACELLT APEIRON CELL THERAPIES
LIVE

Serial Number

79294724

Owner

APEIRON BIOLOGICS AG

Attorney

Julianne Abelman

Filing Date

Aug 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

T ACELLT APEIRON CELL THERAPIES Trademark

Serial Number: 79294724 • Registration: 6799401

T ACELLT APEIRON CELL THERAPIES is a trademark filed by APEIRON BIOLOGICS AG on August 3, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

APEIRON BIOLOGICS AG (10 trademarks)

Campus-Vienna-Biocenter 5

Entity Type: 99

APEIRON Biologics GmbH (3 trademarks)

Campus-Vienna-Biocenter 5

Entity Type: 98

Trademark Details

Filing Date

August 3, 2020

Registration Date

July 26, 2022

Published for Opposition

May 10, 2022

Goods & Services

Chemical, biochemical and biotechnological preparations for industrial and scientific purposes

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for treating and preventing cancer, pharmaceutical preparations for cellular therapy; diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Scientific and technological services and research and design relating thereto, in particular analysis services in the field of research, development and diagnostics, namely, scientific research, medical research for medical applications, development of new products for others; industrial analysis and research services in the field of cancer treatment, cell processing, and cellular therapy

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 11, 2026 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
May 9, 2025 RHRD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 16, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 4, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 28, 2022 FICS
FINAL DISPOSITION PROCESSED
Oct 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 26, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 26, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 26, 2022 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 20, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 20, 2022 REAP
NOTIFICATION PROCESSED BY IB
May 15, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 20, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 4, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 4, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 4, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 4, 2022 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 21, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 2, 2022 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 26, 2021 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 23, 2021 GNFN
FINAL REFUSAL E-MAILED
Jun 23, 2021 GNFR
FINAL REFUSAL WRITTEN
Jun 23, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 9, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 30, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 9, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2020 REPR